ExitValue.ai

ACQUIRED · 2024

Who Acquired Vantive Kidney Care (Baxter)?

Carlyle · $3.80B · 2024

The acquisition

Vantive Kidney Care (Baxter) was acquired by Carlyle in 2024 for $3.80B.

Vantive Kidney Care (Baxter) at time of acquisition

Revenue

$4513.0M

Deal value

$3.80B

Own a medical devices business? See what it's worth.

Carlyle acquired Vantive Kidney Care (Baxter) for $3.80B. Get an M&A-grade EBITDA range and sellability score for your own business, benchmarked against 25,592 real transactions. 2 minutes, no signup.

  • Sellability score with 5-driver breakdown and lift estimates
  • Named comparable M&A transactions in your sub-vertical
  • AI-written analysis grounded in your specific inputs
Run my valuation analysis →

Other acquisitions by Carlyle

Recent transactions by the same buyer — context on their deal flow and footprint.

Similar medical devices acquisitions

More on medical devices valuations

Sourced from SEC filings and press releases. Full deal page

Citation: ExitValue.ai. (2024). Vantive Kidney Care (Baxter) acquired by Carlyle. https://exitvalue.ai/acquired/vantive-kidney-care-baxter